Stock NXTMH NEXSTIM PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Nexstim Plc

Equities

NXTMH

FI4000506811

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Helsinki
Other stock markets
 12:00:00 2024-06-24 EDT 		5-day change 1st Jan Change
2.93 EUR -1.35% Intraday chart for Nexstim Plc -5.48% -0.34%
06-12 Nexstim Plc Provides Further Details on Technology License Agreement with Magnus Medical, Inc CI
06-10 Nexstim plc Receives an Order for an NBS System 5 from A Distributor for A European Hospital CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 7.22 43 31.96 27.6 19.89 19.82 - -
Enterprise Value (EV) 1 9.231 44.58 30.66 26.65 19.89 20.92 20.12 19.82
P/E ratio -0.46 x -4.89 x -34.1 x 22.8 x -14.7 x -293 x 22.5 x 13.3 x
Yield - - - - - - - 1.71%
Capitalization / Revenue 2.16 x 10.5 x 5 x 2.9 x 2.74 x 2.13 x 1.69 x 1.45 x
EV / Revenue 2.76 x 10.8 x 4.79 x 2.8 x 2.74 x 2.25 x 1.72 x 1.45 x
EV / EBITDA -1.54 x -15 x -30.4 x 19.9 x - 26.2 x 11.8 x 8.26 x
EV / FCF - -16.4 x -8.25 x -60.8 x -5.29 x 11.6 x 22.4 x 11.7 x
FCF Yield - -6.11% -12.1% -1.64% -18.9% 8.6% 4.47% 8.58%
Price to Book - - - 6.78 x - 7.92 x 5.86 x -
Nbr of stocks (in thousands) 628 4,396 6,687 6,715 6,766 6,766 - -
Reference price 2 11.50 9.780 4.780 4.110 2.940 2.930 2.930 2.930
Announcement Date 2/28/20 2/26/21 2/28/22 2/27/23 2/27/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3.348 4.114 6.398 9.527 7.246 9.3 11.7 13.7
EBITDA 1 -5.993 -2.966 -1.009 1.338 - 0.8 1.7 2.4
EBIT 1 -6.517 -3.333 -1.452 0.8403 -1.228 - 1 1.8
Operating Margin -194.66% -81.01% -22.7% 8.82% -16.95% - 8.55% 13.14%
Earnings before Tax (EBT) 1 -6.777 -4.117 -0.7333 1.311 - -0.1 0.9 1.6
Net income 1 -6.783 -4.122 -0.8321 1.307 - -0.1 0.9 1.6
Net margin -202.58% -100.18% -13.01% 13.72% - -1.08% 7.69% 11.68%
EPS 2 -25.00 -2.000 -0.1400 0.1800 -0.2000 -0.0100 0.1300 0.2200
Free Cash Flow 1 - -2.725 -3.718 -0.4381 -3.758 1.8 0.9 1.7
FCF margin - -66.23% -58.11% -4.6% -51.86% 19.35% 7.69% 12.41%
FCF Conversion (EBITDA) - - - - - 225% 52.94% 70.83%
FCF Conversion (Net income) - - - - - - 100% 106.25%
Dividend per Share 2 - - - - - - - 0.0500
Announcement Date 2/28/20 2/26/21 2/28/22 2/27/23 2/27/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2 2025 S1 2025 S2
Net sales 1 6.793 2.734 2.504 4.743 3.4 5.9 4.8 7
EBITDA 1 2.553 -1.215 -1.078 - -0.5 1.3 -0.3 1.3
EBIT 1 2.333 -1.493 -1.387 0.1593 -0.9 0.9 -0.3 1.3
Operating Margin 34.35% -54.62% -55.41% 3.36% -26.47% 15.25% -6.25% 18.57%
Earnings before Tax (EBT) 1 3.214 -1.902 -1.439 - -1 0.9 -0.3 1.3
Net income 1 3.209 -1.903 -1.442 - -1 0.9 -0.3 1.3
Net margin 47.25% -69.6% -57.61% - -29.41% 15.25% -6.25% 18.57%
EPS 2 0.4400 -0.2800 -0.2100 - -0.1400 0.1200 -0.0400 0.1800
Dividend per Share - - - - - - - -
Announcement Date 8/12/22 2/27/23 8/18/23 2/27/24 - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2.01 1.59 - - - 1.1 0.3 -
Net Cash position 1 - - 1.3 0.95 - - - -
Leverage (Debt/EBITDA) -0.3355 x -0.5356 x - - - 1.375 x 0.1765 x -
Free Cash Flow 1 - -2.72 -3.72 -0.44 -3.76 1.8 0.9 1.7
ROE (net income / shareholders' equity) - - - 35.9% - -3.8% 28.9% -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 - - - 0.6100 - 0.3700 0.5000 -
Cash Flow per Share 2 - - - 0.1400 -0.2800 0.3300 0.2200 -
Capex 1 0.84 - 1.61 1.44 1.49 0.6 0.7 0.7
Capex / Sales 25.19% - 25.14% 15.12% 20.55% 6.45% 5.98% 5.11%
Announcement Date 2/28/20 2/26/21 2/28/22 2/27/23 2/27/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
1
Last Close Price
2.93 EUR
Average target price
3.4 EUR
Spread / Average Target
+16.04%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
NEXSTIM PLC Stock Nexstim Plc
-0.34% 21.27M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+6.62% 216B
DANAHER CORPORATION Stock Danaher Corporation
+10.99% 190B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+27.18% 152B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+32.69% 113B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+1.71% 64.04B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+18.26% 54.34B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+1.63% 49.21B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-2.84% 39.41B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+1.98% 35.99B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. NXTMH Stock
  4. Financials Nexstim Plc